Growing community of inventors

Milan, Italy

Pier Giuseppe Pelicci

Average Co-Inventor Count = 3.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Pier Giuseppe PelicciRoberto Pellicciari (1 patent)Pier Giuseppe PelicciJose Antonio Ortega Martinez (1 patent)Pier Giuseppe PelicciMarinella Roberti (1 patent)Pier Giuseppe PelicciFrancesca De Franco (1 patent)Pier Giuseppe PelicciGiuseppina Di Stefano (1 patent)Pier Giuseppe PelicciSeyed Amir Hosseini (1 patent)Pier Giuseppe PelicciAndrea Cavalli (1 patent)Pier Giuseppe PelicciDomenico Milano (1 patent)Pier Giuseppe PelicciMarcella Manerba (1 patent)Pier Giuseppe PelicciGreta Bagnolini (1 patent)Pier Giuseppe PelicciSaverio Minucci (1 patent)Pier Giuseppe PelicciViola Previtali (1 patent)Pier Giuseppe PelicciPier Giuseppe Pelicci (2 patents)Roberto PellicciariRoberto Pellicciari (66 patents)Jose Antonio Ortega MartinezJose Antonio Ortega Martinez (4 patents)Marinella RobertiMarinella Roberti (2 patents)Francesca De FrancoFrancesca De Franco (2 patents)Giuseppina Di StefanoGiuseppina Di Stefano (1 patent)Seyed Amir HosseiniSeyed Amir Hosseini (1 patent)Andrea CavalliAndrea Cavalli (1 patent)Domenico MilanoDomenico Milano (1 patent)Marcella ManerbaMarcella Manerba (1 patent)Greta BagnoliniGreta Bagnolini (1 patent)Saverio MinucciSaverio Minucci (1 patent)Viola PrevitaliViola Previtali (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Istituto Europeo Di Oncologia S.r.l. (2 from 10 patents)

2. Fondazione Istituto Italiano Di Tecnologia (1 from 136 patents)

3. Alma Mater Studiorum-Universitá Di Bologna (1 from 78 patents)

4. Universita′ Degli Studi Di Milano (1 from 33 patents)

5. Tes Pharma S.r.l. (1 from 5 patents)


2 patents:

1. 12459914 - Compounds and compositions for the treatment of tumors

2. 11918580 - Use of a combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…